Late Urinary Morbidity With High Dose Prostate Brachytherapy as a Boost to Conventional External Beam Radiation Therapy for Local and Locally Advanced Prostate Cancer

Abstract

HDR-B appears to offer a safe, reproducible and effective method of boosting conventional EBRT in patients with locally advanced prostate cancer. Results with this technology reveal late urinary morbidity rates paralleling those achieved with other forms of treatment, but further long-term followup is still needed to warrant a definitive conclusion.